Christopher Ryan Sullivan

AVTX

Christopher Ryan Sullivan serves as officer: Chief Financial Officer at Avalo Therapeutics, Inc. (AVTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$3.2K

Total Sells

5 trades

$1.68M

Net Position

Net Seller

$1.68M

Companies Traded

AVTX

Active Period

Dec 2021 – May 2026

7 total trades

Most Recent

Sell AVTX

May 11, 2026 · $448.8K

Christopher Ryan Sullivan's Insider Trading at Avalo Therapeutics, Inc. (AVTX)

Buys

2 · $3.2K

Sells

5 · $1.68M

Total Shares Bought

1,466

Total Shares Sold

89,961

AVTX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 11, 2026	Sell	18,606	$24.12	$448.8K	423
May 7, 2026	Sell	47,000	$20.19	$948.7K	33,589
May 1, 2026	Sell	16,915	$13.16	$222.6K	8,880
Dec 10, 2025	Sell	155	$4.10	$635.50	0
Mar 28, 2025	Sell	7,285	$8.46	$61.6K	0
Jun 9, 2023	Buy	511	$3.42	$1.7K	0
Dec 10, 2021	Buy	955	$1.57	$1.5K	0